Stanford V
WikiDoc Resources for Stanford V |
Articles |
---|
Most recent articles on Stanford V |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Stanford V at Clinical Trials.gov Clinical Trials on Stanford V at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Stanford V
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Stanford V Discussion groups on Stanford V Patient Handouts on Stanford V Directions to Hospitals Treating Stanford V Risk calculators and risk factors for Stanford V
|
Healthcare Provider Resources |
Causes & Risk Factors for Stanford V |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Stanford V is a chemotherapy regimen designed for Hodgkin's lymphoma that consists of the following:
It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin's lymphoma.
The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.
It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin's lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.
External links
- Lymphoma Information Network
- PMID 11821442
- Includes table for schedule